GO:0009698 | phenylpropanoid metabolic process | 25.0% (16/64) | 3.14 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 50.0% (32/64) | 1.73 | 0.0 | 0.0 |
GO:0009699 | phenylpropanoid biosynthetic process | 21.88% (14/64) | 3.17 | 0.0 | 0.0 |
GO:0019438 | aromatic compound biosynthetic process | 29.69% (19/64) | 2.35 | 0.0 | 1e-06 |
GO:1901360 | organic cyclic compound metabolic process | 48.44% (31/64) | 1.55 | 0.0 | 1e-06 |
GO:0010224 | response to UV-B | 14.06% (9/64) | 3.93 | 0.0 | 1e-06 |
GO:0009058 | biosynthetic process | 46.88% (30/64) | 1.58 | 0.0 | 1e-06 |
GO:0044249 | cellular biosynthetic process | 43.75% (28/64) | 1.64 | 0.0 | 1e-06 |
GO:0044550 | secondary metabolite biosynthetic process | 23.44% (15/64) | 2.69 | 0.0 | 1e-06 |
GO:1901576 | organic substance biosynthetic process | 45.31% (29/64) | 1.61 | 0.0 | 1e-06 |
GO:0019748 | secondary metabolic process | 26.56% (17/64) | 2.45 | 0.0 | 1e-06 |
GO:0071704 | organic substance metabolic process | 71.88% (46/64) | 0.96 | 0.0 | 2e-06 |
GO:0009411 | response to UV | 17.19% (11/64) | 3.29 | 0.0 | 2e-06 |
GO:0009805 | coumarin biosynthetic process | 9.38% (6/64) | 5.07 | 0.0 | 3e-06 |
GO:0008152 | metabolic process | 73.44% (47/64) | 0.89 | 0.0 | 5e-06 |
GO:0009804 | coumarin metabolic process | 9.38% (6/64) | 4.96 | 0.0 | 5e-06 |
GO:0044237 | cellular metabolic process | 67.19% (43/64) | 0.99 | 0.0 | 5e-06 |
GO:1901362 | organic cyclic compound biosynthetic process | 29.69% (19/64) | 2.06 | 0.0 | 5e-06 |
GO:0003913 | DNA photolyase activity | 4.69% (3/64) | 8.03 | 0.0 | 1.3e-05 |
GO:0010421 | hydrogen peroxide-mediated programmed cell death | 6.25% (4/64) | 6.21 | 0.0 | 2e-05 |
GO:0036474 | cell death in response to hydrogen peroxide | 6.25% (4/64) | 6.21 | 0.0 | 2e-05 |
GO:1990641 | response to iron ion starvation | 7.81% (5/64) | 5.17 | 0.0 | 2.3e-05 |
GO:0036473 | cell death in response to oxidative stress | 6.25% (4/64) | 5.58 | 2e-06 | 0.000107 |
GO:0097468 | programmed cell death in response to reactive oxygen species | 6.25% (4/64) | 5.58 | 2e-06 | 0.000107 |
GO:0009987 | cellular process | 79.69% (51/64) | 0.61 | 5e-06 | 0.000322 |
GO:0009809 | lignin biosynthetic process | 9.38% (6/64) | 3.75 | 6e-06 | 0.000376 |
GO:0016706 | 2-oxoglutarate-dependent dioxygenase activity | 9.38% (6/64) | 3.65 | 9e-06 | 0.000531 |
GO:0050896 | response to stimulus | 65.62% (42/64) | 0.76 | 1.2e-05 | 0.000717 |
GO:0009416 | response to light stimulus | 25.0% (16/64) | 1.75 | 1.4e-05 | 0.000757 |
GO:0003824 | catalytic activity | 59.38% (38/64) | 0.85 | 1.3e-05 | 0.000764 |
GO:0000719 | photoreactive repair | 3.12% (2/64) | 8.25 | 1.6e-05 | 0.000797 |
GO:0003904 | deoxyribodipyrimidine photo-lyase activity | 3.12% (2/64) | 8.25 | 1.6e-05 | 0.000797 |
GO:0009800 | cinnamic acid biosynthetic process | 6.25% (4/64) | 4.76 | 1.5e-05 | 0.000807 |
GO:0009628 | response to abiotic stimulus | 42.19% (27/64) | 1.14 | 1.9e-05 | 0.000946 |
GO:0009808 | lignin metabolic process | 9.38% (6/64) | 3.42 | 2.1e-05 | 0.000999 |
GO:0009314 | response to radiation | 25.0% (16/64) | 1.68 | 2.4e-05 | 0.001118 |
GO:0106145 | scopoletin 8-hydroxylase activity | 4.69% (3/64) | 5.67 | 2.9e-05 | 0.00126 |
GO:0106147 | fraxetin biosynthesis | 4.69% (3/64) | 5.67 | 2.9e-05 | 0.00126 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 14.06% (9/64) | 2.48 | 3.2e-05 | 0.001352 |
GO:0009803 | cinnamic acid metabolic process | 6.25% (4/64) | 4.45 | 3.6e-05 | 0.001479 |
GO:0051213 | dioxygenase activity | 9.38% (6/64) | 3.27 | 3.7e-05 | 0.001514 |
GO:2000831 | regulation of steroid hormone secretion | 3.12% (2/64) | 7.67 | 3.9e-05 | 0.001563 |
GO:0046483 | heterocycle metabolic process | 32.81% (21/64) | 1.32 | 4.2e-05 | 0.001643 |
GO:0009813 | flavonoid biosynthetic process | 9.38% (6/64) | 3.15 | 6e-05 | 0.002269 |
GO:0043167 | ion binding | 39.06% (25/64) | 1.11 | 7e-05 | 0.002592 |
GO:0050563 | trans-feruloyl-CoA synthase activity | 3.12% (2/64) | 6.93 | 0.000118 | 0.004262 |
GO:0010584 | pollen exine formation | 6.25% (4/64) | 3.98 | 0.000126 | 0.004449 |
GO:0018130 | heterocycle biosynthetic process | 17.19% (11/64) | 1.92 | 0.000131 | 0.004531 |
GO:0010927 | cellular component assembly involved in morphogenesis | 7.81% (5/64) | 3.34 | 0.000138 | 0.004586 |
GO:0050660 | flavin adenine dinucleotide binding | 6.25% (4/64) | 3.95 | 0.000135 | 0.004594 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 3.12% (2/64) | 6.67 | 0.000172 | 0.005414 |
GO:0044060 | regulation of endocrine process | 3.12% (2/64) | 6.67 | 0.000172 | 0.005414 |
GO:0010039 | response to iron ion | 6.25% (4/64) | 3.86 | 0.000171 | 0.005586 |
GO:0008150 | biological_process | 82.81% (53/64) | 0.43 | 0.000194 | 0.005987 |
GO:0003674 | molecular_function | 81.25% (52/64) | 0.44 | 0.000203 | 0.006139 |
GO:0009812 | flavonoid metabolic process | 9.38% (6/64) | 2.81 | 0.000219 | 0.006511 |
GO:0071949 | FAD binding | 4.69% (3/64) | 4.63 | 0.00025 | 0.007295 |
GO:0016491 | oxidoreductase activity | 20.31% (13/64) | 1.6 | 0.000274 | 0.007871 |
GO:0018904 | ether metabolic process | 4.69% (3/64) | 4.55 | 0.000292 | 0.008233 |
GO:1900386 | positive regulation of flavonol biosynthetic process | 3.12% (2/64) | 6.25 | 0.000312 | 0.00838 |
GO:0030014 | CCR4-NOT complex | 3.12% (2/64) | 6.25 | 0.000312 | 0.00838 |
GO:0106018 | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 3.12% (2/64) | 6.25 | 0.000312 | 0.00838 |
GO:0044281 | small molecule metabolic process | 25.0% (16/64) | 1.35 | 0.000349 | 0.009225 |
GO:0010208 | pollen wall assembly | 6.25% (4/64) | 3.48 | 0.000468 | 0.012179 |
GO:0006290 | pyrimidine dimer repair | 3.12% (2/64) | 5.93 | 0.000492 | 0.012602 |
GO:0007623 | circadian rhythm | 9.38% (6/64) | 2.55 | 0.000557 | 0.01385 |
GO:0003684 | damaged DNA binding | 4.69% (3/64) | 4.24 | 0.000553 | 0.013951 |
GO:0120255 | olefinic compound biosynthetic process | 6.25% (4/64) | 3.4 | 0.000572 | 0.014003 |
GO:1901615 | organic hydroxy compound metabolic process | 12.5% (8/64) | 2.07 | 0.0006 | 0.014473 |
GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 9.38% (6/64) | 2.52 | 0.000616 | 0.014641 |
GO:0043168 | anion binding | 21.88% (14/64) | 1.37 | 0.000779 | 0.017764 |
GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity | 3.12% (2/64) | 5.61 | 0.000773 | 0.017869 |
GO:0072319 | vesicle uncoating | 3.12% (2/64) | 5.61 | 0.000773 | 0.017869 |
GO:0006629 | lipid metabolic process | 20.31% (13/64) | 1.43 | 0.000835 | 0.018541 |
GO:0044238 | primary metabolic process | 51.56% (33/64) | 0.69 | 0.000831 | 0.018709 |
GO:0048511 | rhythmic process | 9.38% (6/64) | 2.42 | 0.000911 | 0.019693 |
GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity | 3.12% (2/64) | 5.5 | 0.000902 | 0.019764 |
GO:0033494 | ferulate metabolic process | 3.12% (2/64) | 5.45 | 0.000971 | 0.020455 |
GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor | 3.12% (2/64) | 5.45 | 0.000971 | 0.020455 |
GO:0048512 | circadian behavior | 3.12% (2/64) | 5.4 | 0.001041 | 0.021672 |
GO:0007622 | rhythmic behavior | 3.12% (2/64) | 5.35 | 0.001115 | 0.022358 |
GO:0018858 | benzoate-CoA ligase activity | 3.12% (2/64) | 5.35 | 0.001115 | 0.022358 |
GO:0106286 | (E)-caffeate-CoA ligase activity | 3.12% (2/64) | 5.35 | 0.001115 | 0.022358 |
GO:0106290 | trans-cinnamate-CoA ligase activity | 3.12% (2/64) | 5.3 | 0.00119 | 0.02359 |
GO:0016207 | 4-coumarate-CoA ligase activity | 3.12% (2/64) | 5.21 | 0.001349 | 0.026108 |
GO:0052866 | phosphatidylinositol phosphate phosphatase activity | 3.12% (2/64) | 5.21 | 0.001349 | 0.026108 |
GO:0032836 | glomerular basement membrane development | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:0102306 | benzil reductase [(S)-benzoin-forming] activity | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:0003914 | DNA (6-4) photolyase activity | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:0006975 | DNA damage induced protein phosphorylation | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:0042622 | photoreceptor outer segment membrane | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:0050958 | magnetoreception | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:2000118 | regulation of sodium-dependent phosphate transport | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:2000832 | negative regulation of steroid hormone secretion | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:2000846 | regulation of corticosteroid hormone secretion | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:2000847 | negative regulation of corticosteroid hormone secretion | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:2000849 | regulation of glucocorticoid secretion | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:2000850 | negative regulation of glucocorticoid secretion | 1.56% (1/64) | 9.25 | 0.001637 | 0.026727 |
GO:0044255 | cellular lipid metabolic process | 17.19% (11/64) | 1.48 | 0.001689 | 0.027303 |
GO:0006367 | transcription initiation at RNA polymerase II promoter | 3.12% (2/64) | 5.17 | 0.001431 | 0.027392 |
GO:0006368 | transcription elongation by RNA polymerase II promoter | 3.12% (2/64) | 5.13 | 0.001516 | 0.028369 |
GO:0009649 | entrainment of circadian clock | 3.12% (2/64) | 5.13 | 0.001516 | 0.028369 |
GO:0004497 | monooxygenase activity | 9.38% (6/64) | 2.25 | 0.001629 | 0.030141 |
GO:0046474 | glycerophospholipid biosynthetic process | 4.69% (3/64) | 3.56 | 0.002134 | 0.034168 |
GO:0006950 | response to stress | 45.31% (29/64) | 0.69 | 0.002292 | 0.036006 |
GO:0019882 | antigen processing and presentation | 3.12% (2/64) | 4.83 | 0.002282 | 0.036188 |
GO:0009881 | photoreceptor activity | 3.12% (2/64) | 4.8 | 0.002388 | 0.037163 |
GO:0042594 | response to starvation | 9.38% (6/64) | 2.13 | 0.002518 | 0.037763 |
GO:0032559 | adenyl ribonucleotide binding | 15.62% (10/64) | 1.5 | 0.002517 | 0.038099 |
GO:0017004 | cytochrome complex assembly | 3.12% (2/64) | 4.76 | 0.002497 | 0.038138 |
GO:0046394 | carboxylic acid biosynthetic process | 10.94% (7/64) | 1.92 | 0.002478 | 0.038202 |
GO:0030554 | adenyl nucleotide binding | 15.62% (10/64) | 1.5 | 0.002612 | 0.038825 |
GO:0032553 | ribonucleotide binding | 17.19% (11/64) | 1.4 | 0.002666 | 0.039281 |
GO:1903085 | regulation of sinapate ester biosynthetic process | 3.12% (2/64) | 4.67 | 0.002836 | 0.039677 |
GO:1903086 | negative regulation of sinapate ester biosynthetic process | 3.12% (2/64) | 4.67 | 0.002836 | 0.039677 |
GO:0051261 | protein depolymerization | 3.12% (2/64) | 4.67 | 0.002836 | 0.039677 |
GO:0009992 | cellular water homeostasis | 3.12% (2/64) | 4.67 | 0.002836 | 0.039677 |
GO:0006836 | neurotransmitter transport | 3.12% (2/64) | 4.7 | 0.00272 | 0.039733 |
GO:0032984 | protein-containing complex disassembly | 4.69% (3/64) | 3.43 | 0.002772 | 0.040133 |
GO:0006354 | DNA-templated transcription elongation | 3.12% (2/64) | 4.64 | 0.002953 | 0.040977 |
GO:0050877 | nervous system process | 6.25% (4/64) | 2.75 | 0.003028 | 0.041663 |
GO:1900377 | negative regulation of secondary metabolite biosynthetic process | 3.12% (2/64) | 4.61 | 0.003073 | 0.041941 |
GO:0021692 | cerebellar Purkinje cell layer morphogenesis | 1.56% (1/64) | 8.25 | 0.003272 | 0.042897 |
GO:0032194 | ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate | 1.56% (1/64) | 8.25 | 0.003272 | 0.042897 |
GO:0102069 | zerumbone synthase activity | 1.56% (1/64) | 8.25 | 0.003272 | 0.042897 |
GO:1903412 | response to bile acid | 1.56% (1/64) | 8.25 | 0.003272 | 0.042897 |
GO:0120206 | photoreceptor distal connecting cilium | 1.56% (1/64) | 8.25 | 0.003272 | 0.042897 |
GO:0048878 | chemical homeostasis | 14.06% (9/64) | 1.55 | 0.003307 | 0.043023 |
GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 4.69% (3/64) | 3.32 | 0.00341 | 0.043678 |
GO:0120254 | olefinic compound metabolic process | 6.25% (4/64) | 2.7 | 0.003399 | 0.043873 |
GO:0042537 | benzene-containing compound metabolic process | 6.25% (4/64) | 2.65 | 0.003835 | 0.048747 |